Start Your Risk-Free Trial

Levocetirizine — Discount Pricing

Levocetirizine is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.

Levocetirizine Pricing

Pricing typePrice
TheDrugClubDiscount pricing may be available
Typical Retail$19.00

Discount pricing may be available; confirm the price with the dispensing pharmacy.

About Levocetirizine

Levocetirizine is a prescription medication. Ask your doctor if Levocetirizine is right for you.

How to Check Levocetirizine Pricing

  1. Join TheDrugClub for $19.95/month
  2. Receive your member card by email
  3. Present your card at a participating pharmacy
  4. Check active-formulary eligibility or available discount pricing

Levocetirizine at Participating Pharmacies

Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.

Other medications in Respiratory & Allergies

What Levocetirizine is approved for (FDA label)

Levocetirizine dihydrochloride tablets are a histamine H 1 -receptor antagonist indicated for: • The relief of symptoms associated with perennial allergic rhinitis ( 1.1 ) • The treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria ( 1.2 ) 1.1 Perennial Allergic Rhinitis Levocetirizine dihydrochloride tablets are indicated for the relief of symptoms associated with perennial allergic rhinitis in children 6 months to 2 years of age. 1.2 Chronic Idiopathic Urticaria Levocetirizine dihydrochloride tablets are indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older.

Source: Read the full FDA label on DailyMed. Label effective date: September 9, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Dosage forms and strengths for Levocetirizine (FDA label)

Levocetirizine Dihydrochloride Tablets, USP are white, oval, film-coated, biconvex tablets, one side embossed with 'G' break line ‘G’ and the other side plain and contain 5 mg levocetirizine dihydrochloride, USP. • Immediate release breakable (scored) tablets, 5 mg (3)

Source: FDA prescribing information (DailyMed). Set ID: 60ae7e0e-281c-40a3-a0d3-259b843ddaaa. SPL document ID: f6e61e6c-802e-4306-aa91-ba0d31665d9e. Label effective date: September 9, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Levocetirizine (FDA label)

The following clinically significant adverse reactions are described elsewhere in the labeling: • Somnolence [see Warnings and Precautions ( 5.1 )] • Urinary Retention [see Warnings and Precautions ( 5.2 )] • Risk of New Onset Pruritus After Discontinuation of Levocetirizine Dihydrochloride [see Warnings and Precautions ( 5.3 )] The most common adverse reactions (rate ≥2% and > placebo) were somnolence, nasopharyngitis, fatigue, dry mouth, and pharyngitis in subjects 12 years of age and older, and pyrexia, somnolence, cough, and epistaxis in children 6 to 12 years of age. In subjects 1 to 5 years of age, the most common adverse reactions (rate ≥2% and > placebo) were pyrexia, diarrhea, vomiting, and otitis media.

Source: FDA prescribing information (DailyMed). Set ID: 60ae7e0e-281c-40a3-a0d3-259b843ddaaa. SPL document ID: f6e61e6c-802e-4306-aa91-ba0d31665d9e. Label effective date: September 9, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Start Your Risk-Free Trial
Start Your Risk-Free Trial